Emphasizing quality in qualitative research: Devices to control arrhythmias

Journal of Cardiovascular Electrophysiology

Volumn 16, Issue 4, 2005, Pages 391-393

  Exner, Derek V ^a,b,c,d  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^b CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^c Alta Her Found for Med Research   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

CLINICAL RESEARCH; CLINICAL TRIAL; DEFIBRILLATOR; EDITORIAL; FEASIBILITY STUDY; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; LONGEVITY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY OF LIFE; RELIABILITY; SELF REPORT; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 17044386636     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2005.50053.x     Document Type: Editorial

References (24)

1. Chalmers TC, Celano P, Sacks HS, et al: Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983;309(22):1358-1361.
2. Echt DS, Liebson PR, Mitchell LB, et al: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial [see comments]. N Engl J Med 1991;324(12):781-788.
3. Connolly SJ, Hallstrom AP, Cappato R, et al: Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21(24):2071-2078.
4. Nanthakumar K, Epstein AE, Kay GN, et al: Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction. A pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004;44(11):2166-2172.
5. Gregoratos G, Abrams J, Epstein AE, et al: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol 2002;13(11):1183-1199.
6. Jenkins L: Quality of Life in Survivors of Sudden Cardiac Death Entering Treatment. Futura Publishing Company, 1997, pp. 289-305.
7. Steinberg J, Vloka M, Qing Y, et al: Relationship of baseline quality of life scores to long-term survival in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial [abstract]. Circulation 1999;100:1925.
8. Stevenson LW: Inotropic therapy for heart failure. N Engl J Med 1998;339(25):1848-1850.
9. Luderitz B, Jung W, Deister A, et al: Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 1993;16(9):1815-1821.
10. Irvine J, Dorian P, Baker B, et al: Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144(2):282-289.
11. Namerow PB, Firth BR, Heywood GM, et al: Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. Pacing Clin Electrophysiol 1999;22(9):1305-1313.
12. Schron EB, Exner DV, Yao Q, et al: Quality of life in the Antiarrhythmics Versus Implantable Defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105(5):589-594.
13. Neel M: Posttraumatic stress symptomatology inpatients with automatic implantable cardioverter defibrillators: Nature and intervention. Int J Emerg Ment Health Fall 2000;2(4):259-263.
14. Sears SF Jr, Conti JB, Curtis AB, et al: Affective distress and implantable cardioverter defibrillators: Cases for psychological and behavioral interventions. Pacing Clin Electrophysiol 1999;22(12):1831-1834.
15. Begg C, Cho M, Eastwood S, et al: Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276(8):637-639.
16. McDowell I, Claire Newell C: Measuring Health: A Guide to Rating Scales and Questionnaires. 2nd Ed., Oxford: Oxford University Press, 1996.
17. Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res 2002;11(3):193-205.
18. McHorney CA, Ware JE Jr, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31(3):247-263.
19. Fitzpatrick R, Davey C, Buxton MJ, et al: Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2(14):i-iv, 1-74.
20. Garratt AM, Hutchinson A, Russell I: The UK version of the Seattle Angina Questionnaire (SAQ-UK): Reliability, validity and responsiveness. J Clin Epidemiol 2001;54(9):907-915.
21. Terwee CB, Dekker FW, Wiersinga WM, et al: On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation. Qual Life Res 2003;12(4):349-362.
22. Burns J, Serber E, Keim S, Sears S: Measuring patient acceptance of implantable cardiac device therapy: Initial psychometric investigation of the Florida Patient Acceptance Survey (FPAS). J Cardiovasc Electrophysiol 2005;16:384-390.
23. Stofmeel MA, Post MW, Kelder JC, et al: Psychometric properties of Aquarel. A disease-specific quality of life questionnaire for pacemaker patients. J Clin Epidemiol 2001;54(2):157-165.
24. Stofmeel MA, Post MW, Kelder JC, et al: Quality-of-life of pacemaker patients: A reappraisal of current instruments. Pacing Clin Electrophysiol 2000;23(6):946-952.